Hrovat, K.; Rehberger Likozar, A.; Zupan, J.; Šebeštjen, M.
Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors. J. Cardiovasc. Dev. Dis. 2022, 9, 211.
https://doi.org/10.3390/jcdd9070211
AMA Style
Hrovat K, Rehberger Likozar A, Zupan J, Šebeštjen M.
Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors. Journal of Cardiovascular Development and Disease. 2022; 9(7):211.
https://doi.org/10.3390/jcdd9070211
Chicago/Turabian Style
Hrovat, Katja, Andreja Rehberger Likozar, Janja Zupan, and Miran Šebeštjen.
2022. "Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors" Journal of Cardiovascular Development and Disease 9, no. 7: 211.
https://doi.org/10.3390/jcdd9070211
APA Style
Hrovat, K., Rehberger Likozar, A., Zupan, J., & Šebeštjen, M.
(2022). Gene Expression Profiling of Markers of Inflammation, Angiogenesis, Coagulation and Fibrinolysis in Patients with Coronary Artery Disease with Very High Lipoprotein(a) Levels Treated with PCSK9 Inhibitors. Journal of Cardiovascular Development and Disease, 9(7), 211.
https://doi.org/10.3390/jcdd9070211